109 related articles for article (PubMed ID: 25530376)
1. Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early-stage nonseminomatous germ cell tumors.
Su D; Faiena I; Tokarz R; Bramwit M; Weiss RE
Urology; 2015 Jan; 85(1):141-6. PubMed ID: 25530376
[TBL] [Abstract][Full Text] [Related]
2. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.
Tarin TV; Sonn G; Shinghal R
J Urol; 2009 Feb; 181(2):627-32; discussion 632-3. PubMed ID: 19091344
[TBL] [Abstract][Full Text] [Related]
3. Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer.
van Walraven C; Fergusson D; Earle C; Baxter N; Alibhai S; MacDonald B; Forster AJ; Cagiannos I
J Clin Oncol; 2011 Jul; 29(21):2883-8. PubMed ID: 21690479
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Decreased Radiation Exposure From Modern CT Scan Technology and Surveillance Programs of Germ Cell Tumors.
Howard SA; Rosenthal MH; Qin L; Matalon SA; Bernard BD; Beard CJ; Sweeney CJ
Am J Clin Oncol; 2018 Oct; 41(10):949-952. PubMed ID: 28654572
[TBL] [Abstract][Full Text] [Related]
5. [CCAFU Recommendations 2013: Testicular germ cell cancer].
Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
[TBL] [Abstract][Full Text] [Related]
6. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
7. Performance Characteristics of Clinical Staging Modalities for Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Tema G; Patel HD; Gupta M; Sharma R; Zhang A; Bass EB
J Urol; 2020 May; 203(5):894-901. PubMed ID: 31609176
[TBL] [Abstract][Full Text] [Related]
8. Computed Tomography Scans in Patients With Young Adult Hip Pain Carry a Lifetime Risk of Malignancy.
Wylie JD; Jenkins PA; Beckmann JT; Peters CL; Aoki SK; Maak TG
Arthroscopy; 2018 Jan; 34(1):155-163.e3. PubMed ID: 29100768
[TBL] [Abstract][Full Text] [Related]
9. [Relapse surveillance of patients with testicular germ cell tumor].
Orillard E; Klajer E; Kalbacher E; Joly F; David A; Hervé L; Viot J; Mouillet G; Barkatz J; Kleinclauss F; Thiery-Vuillemin A
Bull Cancer; 2019 Oct; 106(10):903-914. PubMed ID: 31495441
[TBL] [Abstract][Full Text] [Related]
10. Microsimulation model of CT versus MRI surveillance of Bosniak IIF renal cystic lesions: should effects of radiation exposure affect selection of imaging strategy?
Kang SK; Turan EA; Eisenberg JD; Lee PA; Kong CY; Pandharipande PV
AJR Am J Roentgenol; 2014 Dec; 203(6):W629-36. PubMed ID: 25415728
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
Heidenreich A; Pfister D
Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
[TBL] [Abstract][Full Text] [Related]
12. Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients.
Cathomas R; Hartmann M; Krege S; Souchon R; Lorch A; Mayer F; De Santis M; Gillessen S;
Onkologie; 2011; 34(1-2):59-64. PubMed ID: 21346388
[TBL] [Abstract][Full Text] [Related]
13. Secondary abdominal-pelvic malignancies attributable to diagnostic radiation exposure in patients with testicular malignancies.
Simone CB
J Clin Oncol; 2012 Jan; 30(1):113-4; author reply 114. PubMed ID: 22105820
[No Abstract] [Full Text] [Related]
14. [Diagnostic parameters and their value in testicular tumors].
Bürgler W; Jaeger P
Urologe A; 1986 May; 25(3):157-9. PubMed ID: 3016965
[TBL] [Abstract][Full Text] [Related]
15. Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors.
Charytonowicz D; Aubrey H; Bell C; Ferret M; Tsui K; Atfield R; Coleman N; Murray MJ; Wilson ECF
Clin Genitourin Cancer; 2019 Aug; 17(4):e733-e744. PubMed ID: 31155478
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic radiation exposure risk in a contemporary cohort of male patients with germ cell tumor.
Silva MV; Motamedinia P; Badalato GM; Hruby G; McKiernan JM
J Urol; 2012 Feb; 187(2):482-6. PubMed ID: 22177144
[TBL] [Abstract][Full Text] [Related]
17. Imaging studies for germ cell tumors.
Sohaib SA; Cook G; Koh DM
Hematol Oncol Clin North Am; 2011 Jun; 25(3):487-502, vii. PubMed ID: 21570604
[TBL] [Abstract][Full Text] [Related]
18. Surveillance results of patients with stage I nonseminomatous germ cell testicular cancer.
Keskin S; Ekenel M; Başaran M; Bavbek S
Onkologie; 2011; 34(4):173-6. PubMed ID: 21447974
[TBL] [Abstract][Full Text] [Related]
19. Comparing risk estimates following diagnostic CT radiation exposures employing different methodological approaches.
Kashcheev VV; Pryakhin EA; Menyaylo AN; Chekin SY; Ivanov VK
Health Phys; 2014 Jun; 106(6):806-11. PubMed ID: 24776915
[TBL] [Abstract][Full Text] [Related]
20. Triple-rule-out computed tomography angiography with 256-slice computed tomography scanners: patient-specific assessment of radiation burden and associated cancer risk.
Perisinakis K; Seimenis I; Tzedakis A; Papadakis AE; Damilakis J
Invest Radiol; 2012 Feb; 47(2):109-15. PubMed ID: 21857528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
